NeuroX1 Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Series C
- Investors
-
7
NeuroX1 General Information
Description
Developer of a computational neuroscience and drug discovery engine designed to identify degenerative disorders of the brain. The company's platform identifies drivers of disease and generative chemistry to produce compounds for those diseases, primarily neurodegenerative, and uses data analytics to design drugs, screen molecules in silicon, and identify small molecules most likely to succeed in clinical trials, enabling the healthcare sector to improve novel disease identification.
Contact Information
Website
www.neurox1.comCorporate Office
- 2205 North Lamar Boulevard
- Unit 223
- Austin, TX 78705
- United States
Corporate Office
- 2205 North Lamar Boulevard
- Unit 223
- Austin, TX 78705
- United States
NeuroX1 Timeline
NeuroX1 Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series C) | 04-Jun-2024 | Completed | Pre-Clinical Trials | |||
| 4. Accelerator/Incubator | 14-Mar-2024 | Completed | Pre-Clinical Trials | |||
| 3. Accelerator/Incubator | 01-Jan-2024 | Completed | Pre-Clinical Trials | |||
| 2. Seed Round | 03-Mar-2023 | $500K | $1.84M | Completed | Pre-Clinical Trials | |
| 1. Seed Round | 31-Dec-2021 | $1.34M | $1.34M | Completed | Pre-Clinical Trials |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
NeuroX1 Comparisons
Industry
Financing
Details
NeuroX1 Competitors (7)
One of NeuroX1’s 7 competitors is Numerion Labs, a Venture Capital-Backed company based in San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Numerion Labs | Venture Capital-Backed | San Francisco, CA | ||||
| Voyager Therapeutics | Formerly VC-backed | Lexington, MA | ||||
| insitro | Venture Capital-Backed | South San Francisco, CA | ||||
| Exscientia | Formerly VC-backed | Oxford, United Kingdom | ||||
| InSilico Medicine Cayman | Formerly VC-backed | Hong Kong, Hong Kong |
NeuroX1 Signals
NeuroX1 Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Techstars | Accelerator/Incubator | Minority | ||
| Next Sequence | Accelerator/Incubator | |||
| Capital Factory | Accelerator/Incubator | Minority | ||
| Drive Capital | Venture Capital | Minority | ||
| Syntax Ventures | Venture Capital | Minority |
NeuroX1 FAQs
-
When was NeuroX1 founded?
NeuroX1 was founded in 2021.
-
Where is NeuroX1 headquartered?
NeuroX1 is headquartered in Austin, TX.
-
What is the size of NeuroX1?
NeuroX1 has 4 total employees.
-
What industry is NeuroX1 in?
NeuroX1’s primary industry is Drug Discovery.
-
Is NeuroX1 a private or public company?
NeuroX1 is a Private company.
-
What is NeuroX1’s current revenue?
The current revenue for NeuroX1 is .
-
How much funding has NeuroX1 raised over time?
NeuroX1 has raised $1.96M.
-
Who are NeuroX1’s investors?
Techstars, Next Sequence, Capital Factory, Drive Capital, and Syntax Ventures are 5 of 7 investors who have invested in NeuroX1.
-
Who are NeuroX1’s competitors?
Numerion Labs, Voyager Therapeutics, insitro, Exscientia, and InSilico Medicine Cayman are some of the 7 competitors of NeuroX1.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process